ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 29 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,927,593 | 0.0% | 4,326,710 | 0.0% | 0.16% | -3.0% |
| Q2 2023 | $5,927,593 | +8.0% | 4,326,710 | +86.0% | 0.16% | -17.9% |
| Q1 2023 | $5,491,036 | +1.7% | 2,326,710 | 0.0% | 0.20% | -11.8% |
| Q4 2022 | $5,397,967 | -15.9% | 2,326,710 | 0.0% | 0.23% | -14.0% |
| Q3 2022 | $6,422,000 | +13.1% | 2,326,710 | 0.0% | 0.26% | -3.3% |
| Q2 2022 | $5,677,000 | -38.1% | 2,326,710 | 0.0% | 0.27% | -25.3% |
| Q1 2022 | $9,167,000 | +50.8% | 2,326,710 | +68.8% | 0.37% | +66.1% |
| Q4 2021 | $6,077,000 | -27.9% | 1,378,020 | +1.1% | 0.22% | -32.8% |
| Q3 2021 | $8,426,000 | -4.3% | 1,363,435 | +22.5% | 0.33% | -0.3% |
| Q2 2021 | $8,807,000 | -26.1% | 1,113,435 | 0.0% | 0.33% | -26.2% |
| Q1 2021 | $11,914,000 | – | 1,113,435 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $8,280,000 | 0.60% |
| CM Management, LLC | 75,000 | $464,000 | 0.35% |
| BVF INC/IL | 1,363,435 | $8,426,000 | 0.33% |
| Cormorant Asset Management, LP | 1,305,095 | $8,065,000 | 0.33% |
| Ikarian Capital, LLC | 344,578 | $2,129,000 | 0.15% |
| Woodline Partners LP | 781,376 | $4,829,000 | 0.08% |
| Eversept Partners, LP | 114,008 | $704,569 | 0.05% |
| INGALLS & SNYDER LLC | 51,149 | $316,000 | 0.01% |
| Virtu Financial LLC | 18,610 | $115,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,630 | $214,000 | 0.01% |